ChemoMetec A/S/€CHEMM
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About ChemoMetec A/S
ChemoMetec A/S is engaged in the development, manufacturing, and marketing of analytical instruments used for counting and analyzing cells in a variety of applications across biotechnology, pharmaceuticals, and academic research sectors. The company’s main product lines include automated cell counters and analyzers, such as the NucleoCounter series. Founded in 1997, ChemoMetec is headquartered in Allerod, Denmark. The company is noted for its focus on innovation in cell counting technology, providing precise and user-friendly solutions that facilitate laboratory workflows and enhance data accuracy. Its strategic position in the analytical instruments industry is strengthened by its commitment to quality and reliability in measurement instrumentation.
Ticker
€CHEMM
Sector
Primary listing
XGAT
Employees
172
Headquarters
Allerød, Denmark
Website
ChemoMetec A/S Metrics
BasicAdvanced
€961M
40.52
€1.36
1.35
€0.94
1.70%
Price and volume
Market cap
€961M
Beta
1.35
52-week high
€106.30
52-week low
€49.10
Average daily volume
1.4K
Dividend rate
€0.94
Financial strength
Current ratio
3.93
Quick ratio
3.023
Long term debt to equity
0.438
Total debt to equity
0.799
Dividend payout ratio (TTM)
68.81%
Interest coverage (TTM)
172.83%
Profitability
EBITDA (TTM)
32.674
Gross margin (TTM)
95.54%
Net profit margin (TTM)
35.90%
Operating margin (TTM)
46.86%
Effective tax rate (TTM)
22.58%
Revenue per employee (TTM)
€384,060
Management effectiveness
Return on assets (TTM)
19.08%
Return on equity (TTM)
28.31%
Valuation
Price to earnings (TTM)
40.523
Price to revenue (TTM)
14.545
Price to book
11.01
Price to tangible book (TTM)
14.82
Price to free cash flow (TTM)
49.685
Free cash flow yield (TTM)
2.01%
Free cash flow per share (TTM)
1.11
Dividend yield (TTM)
1.70%
Forward dividend yield
1.70%
Growth
Revenue change (TTM)
7.31%
Earnings per share change (TTM)
4.62%
3-year revenue growth (CAGR)
2.25%
10-year revenue growth (CAGR)
20.67%
3-year earnings per share growth (CAGR)
-0.48%
10-year earnings per share growth (CAGR)
28.72%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ChemoMetec A/S stock?
ChemoMetec A/S (CHEMM) has a market cap of €961M as of March 20, 2026.
What is the P/E ratio for ChemoMetec A/S stock?
The price to earnings (P/E) ratio for ChemoMetec A/S (CHEMM) stock is 40.52 as of March 20, 2026.
Does ChemoMetec A/S stock pay dividends?
Yes, the ChemoMetec A/S (CHEMM) stock pays dividends to shareholders. As of March 20, 2026, the dividend rate is €0.93703 and the yield is 1.7%. ChemoMetec A/S has a payout ratio of 68.81% on a trailing twelve-month basis.
When is the next ChemoMetec A/S dividend payment date?
The next ChemoMetec A/S (CHEMM) dividend payment date is unconfirmed.
What is the beta indicator for ChemoMetec A/S?
ChemoMetec A/S (CHEMM) has a beta rating of 1.35. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.